GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced at the Radiological Society of North America’s 99 th Scientific Assembly and Annual Meeting in Chicago, Illinois that its 510(k)-pending Revolution CT^ has captured a motion free image of the human heart in just one beat.
Revolution: a breakthrough, ultra-fast CT scanner from GE Healthcare (Photo: Business Wire)
This innovative technology enables clinicians to non-invasively visualize the human heart more clearly than ever before, and diagnose more patients with erratic or high heart beats. According to published literature (the British Journal of Radiology), more than 60 percent of patients referred to cardiac CT today were found to have heart rates higher than 60 beats per minute, and some are turned away from being scanned. With Revolution CT, clinicians can clearly see specific areas of the heart that were previously compromised either by a patient’s movement, high heart rate, or a child’s inability to hold his or her breath. The images were captured by Dr. Ricardo C. Cury, chairman of Radiology and director of Cardiac Imaging at Baptist Health South Florida. According to Cury, physicians no longer will be forced to choose between CT systems with wide coverage, high spatial resolution (clear image), or high temporal resolution (speed). For the first time, GE Healthcare’s Revolution CT converges these three technology advances into one CT system. “This is innovation at its best and is really an all-in-one scanner,” said Cury, chairman of Radiology and director of Cardiac Imaging at Baptist Health South Florida. “Diagnostic quality images are now possible in challenging patients like those with high heart rates, which is a significant advancement. The impressive ability of Revolution to combine coverage, spatial and temporal resolution in a single scanner will translate to many clinical applications and potentially new applications in the future.” Investigational clinical images to demonstrate the capabilities of the scanner were obtained in collaboration with West Kendall Baptist Hospital (WKBH). Dr. Cury served as principal investigator for this study.